Trials / Completed
CompletedNCT03938753
Quality Control of CE-Certified Phonak Hearing Aids - 2018_42
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Sonova AG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).
Detailed description
In this study one CE-labeled Phonak Receiver-in-the-canal (RIC) devices is investigated. The experimental device will be investigated regarding Sound Quality perception ot the T-Coil program. A secondary objective of this study is the investigation of the Overall system stability in daily life situations. The experimental device contains direct connectivity functionality and a T-Coil. The combination of a wireless chip for Bluetooth streaming and a T-Coil in one housing can cause audible artifacts on the T-Coil, which shall be investigated within this study. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Audéo M90-T | Receiver in the canal (RIC) Hearing aid form Phonak which will be fitted to the participants individual Hearing loss. |
Timeline
- Start date
- 2019-01-09
- Primary completion
- 2019-02-07
- Completion
- 2019-02-28
- First posted
- 2019-05-06
- Last updated
- 2019-05-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03938753. Inclusion in this directory is not an endorsement.